Goodwin Lab
Systemic steroids are commonly used in clinical practice for many conditions with varying degrees of efficacy and usually unfavorable side effect profiles. The Goodwin Lab is interested in understanding the effects of steroid microenvironments on whole-organism phenotypes and how these effects could be translated into novel tissue-specific therapeutic approaches. We also have a particular interest in understanding the connection between cardiovascular and renal diseases including the key cell types that mediate cardiorenal crosstalk and opportunities for cell-specific steroid intervention.
Principal Investigator
Julie Goodwin, MD
Associate Professor of Pediatrics (Nephrology)